#13629 on the rich list of 14,644 insiders
Ted W. Love
Director at Royalty Pharma; Director at Gilead Sciences; Director at Jazz Pharmaceuticals. Based in Liberty Corner, New Jersey.
$5.5M
in disclosed stock, −$97K (−1.75%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 13629th of 14,644
- Companies held
- 4
- Largest holding
- RPRX, 72.6% of total
- Latest SEC filing
- Sep 17, 2026
What the $5.5M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Royalty Pharma RPRX Class A Ordinary Shares | Directly | 58,393 | $67.72 | $4.0M | 72.6% | Form 4, Jun 5, 2026 |
| Gilead Sciences GILD Common Stock | Directly | 5,484 | $166.53 | $913K | 16.8% | Form 4, Apr 30, 2026 |
| Jazz Pharmaceuticals JAZZ Ordinary Shares | Directly | 2,389 | $236.45 | $565K | 10.4% | Form 4, Aug 31, 2026 |
| Lisata Therapeutics LSTA Common Stock | Directly | 19,260 | $0.91 | $18K | 0.3% | Form 3, Sep 17, 2026 |
Share counts are the amounts Ted W. Love reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 13626 | Sonsteby, Charles M Director, Darden Restaurants. Orlando, FL | $5.5M |
| 13627 | John C. Ivascu EVP, General Counsel & CCO, Forum Energy Technologies. Houston, TX | $5.5M |
| 13628 | Daniel Heaf CEO, Bath & Body Works. Columbus, OH | $5.5M |
| 13629 | Ted W. Love Director, Royalty Pharma. Liberty Corner, NJ | $5.5M |
| 13630 | John E. Alexander Director, Tompkins Financial. Ithaca, NY | $5.4M |
| 13631 | Daniel R. Henry CEO and President, Green Dot. Henderson, NV | $5.4M |
| 13632 | David A. Montecalvo SVP, Glob Ops and Supply Chain, West Pharmaceutical Services. Exton, PA | $5.4M |
Other Royalty Pharma insiders
All RPRX insiders- Pablo G. Legorreta$335MCEO, Chairman of the Board. #516 overall
- George W. Lloyd$184MEVP, Investments & CLO. #939 overall
- Terrance P. Coyne$132MEVP & CFO. #1225 overall
- James F. Reddoch$57.3MEVP & Chief Scientific Officer. #2308 overall
- Rory B. Riggs$28.5MDirector. #2663 overall
- Christopher Hite$13.6MEVP & Chairman, Partnering. #6964 overall
Questions
How much stock does Ted W. Love own?
Ted W. Love holds $5,450,030 in listed stock based on SEC filings and current prices, mostly Royalty Pharma (RPRX). That ranks 13629th on the Stock Rich List.
Is this Ted W. Love's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.